China Life stock gains on stronger interim profit and higher new business value

China Life Insurance Company Ltd. stock (ISIN CNE1000003V0) is trading against the backdrop of recently reported interim results showing net profit of RMB 24.0 billion for the first half of 2026, up 16.1 percent year on year. As of September 18, 2026, the H share closed at HKD 14.92 on the Hong Kong Stock Exchange, and investors are weighing the mix of slightly lower premium income and stronger profitability in the core life insurance business.

Interim 2026 results highlight profit growth

According to Futunn, China Life reported premium income from the life insurance business of RMB 190.4 billion in the first half of 2026, representing a 1.6 percent decline compared with the same period a year earlier. In the same interim period, net profit reached RMB 24.0 billion, an increase of 16.1 percent year on year, underscoring that profitability improved even as top-line life premium growth softened.

The company also delivered a notable improvement in value creation: new business value, a key metric for future profit potential, rose to RMB 10.8 billion in the first half of 2026, up 12.7 percent from the prior-year period, according to the same interim disclosure by Futunn. This combination of higher new business value and higher net profit despite lower premium income points to a focus on more profitable products and improved underwriting or investment results.

Product mix and customer metrics in focus

In the interim reporting period from January 1 to June 30, 2026, management highlighted that the life insurance business remains the core earnings driver, even as some segments face volume pressure. According to Futunn, the decline in premium income of 1.6 percent contrasts with the 12.7 percent increase in new business value, indicating that the company is selling a more profitable mix of policies and possibly emphasizing protection-type products with higher margins over pure savings products.

For retail investors, the key takeaway from the interim figures is that China Life managed to grow net profit faster than new business value while absorbing a modest decline in premium income in the first half of 2026. This suggests that cost control, claims experience, or investment returns contributed to the 16.1 percent year-on-year rise in net profit from RMB 20.7 billion to RMB 24.0 billion in the period, based on the comparative figures presented by Futunn. The contrast between a lower premium base and higher profitability is likely to be central to how analysts frame the stock in the coming months.

Stock valuation anchored by Hong Kong listing

China Life stock primarily trades in Hong Kong, and the H share price provides the main reference for valuation in local currency terms as of mid September 2026. Per market data for September 18, 2026, the stock closed around HKD 14.92, which places it below earlier peaks seen over the past 52 weeks and reflects the market’s cautious stance despite the double-digit growth in net profit and new business value in the first half of 2026. With a price in the mid teens in Hong Kong dollar terms and a market capitalization in the hundreds of billions of Hong Kong dollars as of the same date, the stock is sensitive to changes in expectations for growth in premium income and future returns on its large investment portfolio.

More news and analyses on China Life stock